The London office of Haynes Boone has advised Isomer Capital, a London-based private investment firm focusing on European venture capital, on the successful first close of its inaugural €100m secondaries fund, Isomer Capital Secondaries I SCSp (the Fund).
The Haynes Boone investment management team representing Isomer included Karma Samdup, the head of private funds and venture in Europe, Investment Management Partner Ronan McCann and London Associate William Barrott.
“The Haynes Boone team continue to provide excellent legal and commercial advice,” said Isomer Managing Partner Joe Schorge. “Having worked together for many years now, they fully understand the Isomer ethos and process, and we really appreciate the value that this long-term relationship brought to this mandate from start to finish. We look forward to continuing to work with Karma, Ronan, Will and the rest of team.”
Isomer has historically leveraged its position as Europe’s VC partner to spot and execute on exciting secondary opportunities within its flagship vehicles, and with the launch of the Fund, it now has a dedicated platform to build on this strategy. The Fund will predominantly buy stakes in European-based VC funds as well as transacting in a select number of direct secondaries.
“We are proud to be long-time supporters of the Isomer team, having worked with them since their inception in 2016,” Samdup said. “It has been fantastic to support them with the launch their new secondaries-focused fund. We look forward to continuing to assist Isomer with future fund closings and their next projects.”
“We are thrilled to have been on team Isomer for the launch of their latest fund, helping bring in an impressive LP base, which, coupled with the exciting opportunities in the secondary market, we are sure will result in a huge success,” added McCann.
The Isomer team has been joined by Omolade Adebisi, who brings extensive secondaries market experience gained at Coller Capital to the Fund.
“It was a pleasure to collaborate with the Haynes Boone team for this pivotal fund launch” Omolade added. “Their support and guidance have been invaluable in bringing Isomer’s first dedicated secondaries fund to the market.”
Isomer already has two deals set to close in May, with more in the pipeline.
